In October 2023, Structure Therapeutics Inc. closed the transaction. The company has disclosed the placement agent expenses of $17,999,999.721 in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.3 USD | +3.84% | +55.44% | +38.13% |
09:46am | Structure Therapeutics Prices Upsized $476 Million Stock Offering | MT |
Jun. 03 | Structure Therapeutics Plans Offering of American Depositary Shares | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.13% | 2.62B | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+5.07% | 22.67B | |
-9.63% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Structure Therapeutics Inc. announced that it has received $299.999996 million in funding